Delivery Order SPE2DX22D0010-SPE2D826FAY39
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 13, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $13,210.51. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Percocet tablets (10/325 mg), a controlled pain management pharmaceutical. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of approximately $35.4K, with an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $40,640.81. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Percocet tablets (5/325 mg), a controlled pain management pharmaceutical. This is a firm fixed-price delivery order with a ceiling value of $3,128.09 and an ultimate completion date of August 26, 2025. The contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $17,828.87 to AmerisourceBergen Drug Corp for Percocet tablets (10/325 mg) on August 25, 2025, with completion by August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a $21,399.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Percocet Tablets (10/325 mg) on October 6, 2025, with completion targeted for October 7, 2025. This is an unset-aside, competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The U.S. Defense Department's Medical Supply Chain awarded a $6,403.30 delivery order to AmerisourceBergen Drug Corp for Percocet tablets (5/325 mg) with a completion date of October 31, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- This delivery order, awarded on August 7, 2025, represents a $40,288.46 firm fixed price contract for Percocet Tabs 10/325 (oxycodone/acetaminophen) issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a child award, indicating it derives from a larger indefinite delivery vehicle. No set-aside designation was applied to this competitive award. The ultimate completion date is set for August 8, 2025, with performance to occur...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation. The $3,829.90 contract requires the delivery of Percocet tablets to a location in Conshohocken, Pennsylvania by February 1, 2024. This delivery order was issued under an indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAY39Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Percocet Tabs 10/325 mg with a ceiling value of $36,165.79. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract requires completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the prime vehicle for global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's existing contract portfolio demonstrates extensive experience delivering controlled substances and pain management pharmaceuticals, along with specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for opioid pain management medication reflects the company's ongoing role as a primary pharmaceutical supplier for Defense Health Agency and other federal healthcare customers through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.2k | 11/10/25 |